Nation Thailand
Covid-19 severity mirrors influenza as vaccine development lags
Compiled by KHAO Editorial — aggregated from 1 outlet. See llms.txt for citation guidance.
◌ Single Source
Prof Yong Poovorawan, head of the Centre of Excellence in Clinical Virology at the Faculty of Medicine, Chulalongkorn University, has highlighted the continuing challenge of developing vaccines quickly enough to keep pace with rapidly evolving viruse
Key facts
- CKPower Advances into Second Half of 2026 with Additional 5 MW of Solar Capacity
- In a post on his personal Facebook account on Monday (September 7), Yong wrote that vaccine development inevitably trails viral evolution, particularly in the case of RNA viruses, which change continuously and relatively quickly.
- Current approaches to Covid-19 and influenza vaccines remain largely focused on catching up rather than staying ahead, he explained
- Yong identified RK.1 as the Covid-19 variant currently circulating in Thailand, describing it as a descendant of NB.1.8.1, which spread last year
Summary
Health & Wellness
In a post on his personal Facebook account on Monday (September 7), Yong wrote that vaccine development inevitably trails viral evolution, particularly in the case of RNA viruses, which change continuously and relatively quickly.